2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …
The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …
Global burden of heart failure: a comprehensive and updated review of epidemiology
G Savarese, PM Becher, LH Lund… - Cardiovascular …, 2022 - academic.oup.com
Heart Failure (HF) is a multi-faceted and life-threatening syndrome characterized by
significant morbidity and mortality, poor functional capacity and quality of life, and high costs …
significant morbidity and mortality, poor functional capacity and quality of life, and high costs …
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and …
Authors/Task Force Members:… - European journal of …, 2022 - Wiley Online Library
Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …
Global epidemiology of cirrhosis—aetiology, trends and predictions
Cirrhosis is an important cause of morbidity and mortality in people with chronic liver
disease worldwide. In 2019, cirrhosis was associated with 2.4% of global deaths. Owing to …
disease worldwide. In 2019, cirrhosis was associated with 2.4% of global deaths. Owing to …
Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
BS Sheena, L Hiebert, H Han, H Ippolito… - The lancet …, 2022 - thelancet.com
Background Combating viral hepatitis is part of the UN Sustainable Development Goals
(SDGs), and WHO has put forth hepatitis B elimination targets in its Global Health Sector …
(SDGs), and WHO has put forth hepatitis B elimination targets in its Global Health Sector …
[HTML][HTML] Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025
X Lin, Y Xu, X Pan, J Xu, Y Ding, X Sun, X Song… - Scientific reports, 2020 - nature.com
Diabetes mellitus is a leading cause of mortality and reduced life expectancy. We aim to
estimate the burden of diabetes by type, year, regions, and socioeconomic status in 195 …
estimate the burden of diabetes by type, year, regions, and socioeconomic status in 195 …
[HTML][HTML] Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study
KE Rudd, SC Johnson, KM Agesa, KA Shackelford… - The Lancet, 2020 - thelancet.com
Background Sepsis is life-threatening organ dysfunction due to a dysregulated host
response to infection. It is considered a major cause of health loss, but data for the global …
response to infection. It is considered a major cause of health loss, but data for the global …
[HTML][HTML] Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
Background Health system planning requires careful assessment of chronic kidney disease
(CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non …
(CKD) epidemiology, but data for morbidity and mortality of this disease are scarce or non …
Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study
GA Gregory, TIG Robinson, SE Linklater… - The lancet Diabetes & …, 2022 - thelancet.com
Background Accurate data on type 1 diabetes prevalence, incidence, associated mortality
and life expectancy are crucial to inform public health policy, but these data are scarce. We …
and life expectancy are crucial to inform public health policy, but these data are scarce. We …
mRNA-based therapeutics: powerful and versatile tools to combat diseases
S Qin, X Tang, Y Chen, K Chen, N Fan… - Signal transduction and …, 2022 - nature.com
The therapeutic use of messenger RNA (mRNA) has fueled great hope to combat a wide
range of incurable diseases. Recent rapid advances in biotechnology and molecular …
range of incurable diseases. Recent rapid advances in biotechnology and molecular …